Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 214 entries
View as:

Feasibility and Preliminary Efficacy of Hatha Yoga in Head and Neck Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT01951664 Org: User:
Start: 08/31/13 End: 10/31/15 Due: 10/31/16

Navigated Early Survivorship Transition in Patients With Newly Diagnosed Cancer and Their Caregivers

Phase: N/A Priority: Normal
NCT ID: NCT02440737 Org: User:
Start: 05/31/15 End: 12/31/18 Due: 12/31/19

Pemetrexed and Oxaliplatin in Treating Patients With Metastatic Solid Tumors or Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00470405 Org: User:
Start: 05/31/04 End: 11/30/07 Due: 11/30/08

Nivolumab in Treating Patients With Stage IV or Recurrent Lung Cancer With High Mutation Loads

Phase: N/A Priority: Normal
NCT ID: NCT03023904 Org: User:
Start: 12/29/17 End: 07/30/20 Due: 07/30/21

Ph II Atrasentan + DOXIL in Recurrent Ovarian/Fallopian/Peritoneal Serous Papillary Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00653328 Org: User:
Start: 05/31/03 End: 03/31/09 Due: 03/31/10

Gene Expression Profiles in Predicting Survival of Patients With Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00897052 Org: User:
Start: 02/28/05 End: 12/31/07 Due: 12/31/08

Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00466856 Org: User:
Start: 12/31/03 End: 10/31/07 Due: 10/31/08

Rituximab, Lenalidomide, and Nivolumab in Treating Participants With Relapsed or Refractory Non-Germinal Center Type Diffuse Large B Cell Lymphoma or Primary Central Nervous System Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03558750 Org: User:
Start: 06/14/18 End: 04/16/19 Due: 04/16/20

Protein Expression in Tumor Tissue Samples From Patients With Cancer of the Oropharynx

Phase: N/A Priority: Normal
NCT ID: NCT00899340 Org: User:
Start: 05/31/06 End: 03/31/08 Due: 03/31/09

Erlotinib and Everolimus in Treating Patients With Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00574366 Org: User:
Start: 12/31/05 End: 02/28/09 Due: 02/28/10

Celecoxib in Treating Patients With Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00653250 Org: User:
Start: 12/31/00 End: 01/31/08 Due: 01/31/09

Trametinib in Treating Patients With Advanced Melanoma With BRAF Non-V600 Mutations

Phase: N/A Priority: Normal
NCT ID: NCT02296112 Org: User:
Start: 01/31/15 End: 04/16/21 Due: 04/16/22

Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00755040 Org: User:
Start: 10/31/08 End: 05/31/16 Due: 05/31/17

Evaluation of Patients With Breast Cancer Using DCE-MRI, MRS, and Proteomics

Phase: N/A Priority: Normal
NCT ID: NCT00656604 Org: User:
Start: 11/30/03 End: 01/31/08 Due: 01/31/09

ALL-Active: A Family-Based Lifestyle Program for Pediatric Acute Leukemia Patients

Phase: N/A Priority: Normal
NCT ID: NCT01901367 Org: User:
Start: 05/31/13 End: 09/30/15 Due: 09/30/16

Ultra High Field MRI and MRS Techniques in Diagnosing Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01938651 Org: User:
Start: 01/31/13 End: 06/30/15 Due: 06/30/16

PET/CT Evaluation of Treatment Response in Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01222416 Org: User:
Start: 10/31/10 End: 04/30/15 Due: 04/30/16

National Registry and Blood Bank of Patients With Liver Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00482365 Org: User:
Start: 04/30/02 End: 08/31/09 Due: 08/31/10

Assessing Benefits of NIRAF Detection for Identifying Parathyroid Glands During Total Thyroidectomy.

Phase: N/A Priority: Normal
NCT ID: NCT04281875 Org: User:
Start: 03/16/20 End: 02/23/24 Due: 02/23/25

Gabapentin Compared to Standard of Care in Preventing Mucositis in Patients With Stage III-IV Head and Neck Cancer Undergoing Primary or Adjuvant Chemoradiation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02480114 Org: User:
Start: 07/31/15 End: 01/31/20 Due: 01/31/21

Bortezomib and Temozolomide in Treating Patients With Advanced Refractory Solid Tumors or Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00512798 Org: User:
Start: 06/30/03 End: 03/31/08 Due: 03/31/09

Studying Biomarkers in Patients With Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00900003 Org: User:
Start: 05/31/07 End: 03/31/13 Due: 03/31/14

COVID-19 and Cancer Consortium Registry

Phase: N/A Priority: Normal
NCT ID: NCT04354701 Org: User:
Start: 03/17/20 End: 12/31/29 Due: 12/31/30

Analysis of Dendritic Phenotype and Function of Patients Receiving VEGF-Trap on VGFT-ST-0202

Phase: N/A Priority: Normal
NCT ID: NCT00896662 Org: User:
Start: 01/31/05 End: 08/31/08 Due: 08/31/09

A Combined Biomarker Model for Risk Stratification of Indeterminate Pulmonary Nodules

Phase: N/A Priority: Normal
NCT ID: NCT06074133 Org: User:
Start: 03/07/24 End: 03/31/29 Due: 03/31/30